Влияние внутривенного лазерного облучения крови на динамику гликозаминогликанов у больных ревматоидным артритом

Abstract

The purpose of this work is to study the content of glycosaminoglycans in the serum of patients with rheumatoid arthritis and their dynamics in complex therapy of intravenous laser irradiation of blood. Materials and methods: 102 patients with a diagnosis of rheumatoid arthritis were examined. Diagnosis was made according to the criteria ACR/EULAR (American College of Rheumatology/European League Against Rheumatism 2010г.). All patients were divided into two groups: basic and control. In the control group, patients received only traditional drug therapy. The main group consisted of patients who received conventional medical therapy in addition, the course of intravenous laser therapy. Results. Before treatment the level of glycosaminoglycans was significantly higher than the norm and made up in the main group 0,718±0,069 g/l (p<0,01), in the control group level amounted to 1,048±has 0.168 g/l (p<0,01). After treatment only in the main group level of glycosaminoglycans decreased significantly to values ​​of the norm, making 0,410±0,032 g / l (p<0,001). The control group didn’t decrease in glycosaminoglycans reached standards (0,799±0,138 g / l) and was not statistically significant (p>0,05). Conclusions: The use of intravenous laser irradiation of blood in rheumatoid arthritis patients in the combined treatment with conventional drug therapy allows to normalize the level of glycosaminoglycans in the serum.